This study provides a comprehensive exploration of ALDH1A3’s multifaceted impact on breast cancer, elucidating its roles in CSC maintenance and tumor heterogeneity, EMT and MET, and metabolic reprogramming. Here, ALDH1A3 is linked to neoplasm.